These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 981165)

  • 21. [Current drug prevention of thromboembolism within the scope of basic inpatient medical management].
    Wegner D; Damme J; Trautmann H
    Z Arztl Fortbild (Jena); 1990; 84(7):317-9. PubMed ID: 2378108
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems of heparin dosage].
    Mombelli G
    Schweiz Med Wochenschr; 1984 Apr; 114(15):524-8. PubMed ID: 6729418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of low molecular weight heparin.
    Thomas DP
    Thromb Haemost; 1986 Dec; 56(3):241-2. PubMed ID: 3563958
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of thromboembolism with heparin and dihydroergotamine in a trauma surgery patient sample--comparison of the effectiveness of different administration forms of dihydroergotamine].
    Schott G; Elsel W; Möckel G; Rothe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(19):973-6. PubMed ID: 1441633
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of thrombo-embolism during radiotherapy of carcinoma of the uterine cervix (author's transl)].
    Joswig EH; Joswig-Priewe H
    Geburtshilfe Frauenheilkd; 1973 Dec; 33(12):988-93. PubMed ID: 4785280
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relationship between various forms of prevention of thromboembolic complications and location of deep vein thrombi (author's transl)].
    Stutz P; Gruber UF
    Schweiz Rundsch Med Prax; 1978 Sep; 67(37):1355-8. PubMed ID: 693462
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis].
    Haas S
    Dtsch Med Wochenschr; 1995 Apr; 120(14):503. PubMed ID: 7712947
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of thromboembolic disease in urologic surgery with low-dose heparin].
    Lancina Martín JA; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986; 39(9):591-7. PubMed ID: 3827326
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin induced bleeding.
    Hirsh J
    Nouv Rev Fr Hematol (1978); 1984; 26(4):261-6. PubMed ID: 6382162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The risk of thromboembolism in prosthetic surgery of the hip, and its prevention by administration of individualized heparin dosages].
    Hernandez-Vaquero D
    Acta Orthop Belg; 1990; 56(2):445-50. PubMed ID: 2239191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G
    Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [From heparin to synthetic antithrombotic drugs].
    Palareti G; Cosmi B
    Minerva Anestesiol; 2001 Sep; 67(9 Suppl 1):76-81. PubMed ID: 11778099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous low dose heparin in the prevention of postoperative thromboembolic complications.
    Kroese A; Dobloug I
    J Oslo City Hosp; 1976 Apr; 26(4):45-7. PubMed ID: 1263020
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of thromboembolism in hip fracture: unfractionated heparin versus low molecular weight heparin ( a prospective, randomized study)].
    Platz A; Hoffmann R; Kohler A; Bischof T; Trentz O
    Z Unfallchir Versicherungsmed; 1993; 86(3):184-8. PubMed ID: 8130009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparin-induced type II thrombocytopenia in intensive care].
    Koster A; Meyer O; Kukucka M; Mertzlufft F; Kuppe H
    Wien Klin Wochenschr; 2001; 113 Suppl 1():14-8. PubMed ID: 15503587
    [No Abstract]   [Full Text] [Related]  

  • 36. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
    Lindblad B
    Acta Chir Scand Suppl; 1988; 543():31-42. PubMed ID: 3055779
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prophylaxis of thrombo-embolic complications in major surgery of the hip joint. A comparative controlled study with subcutaneous calcium heparinate and acetylsalicylic acid (author's transl)].
    Hey D; Heinrich D; Burkhardt H
    Munch Med Wochenschr; 1973 Nov; 115(44):1967-70. PubMed ID: 4801763
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-molecular-weight heparin: from the bench to the orthopedic patient.
    Turpie AG
    Orthopedics; 1997 Feb; 20 Suppl():10-3. PubMed ID: 9048401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of surgery of bronchogenic carcinoma (1958--1972) (author's transl)].
    Kessler E; Wolf FJ
    Prax Klin Pneumol; 1978 Aug; 32(8):513-20. PubMed ID: 683943
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of thromboembolic complications with intravenous heparin in polytrauma].
    Reilmann H; Bosch U; Kleemann WJ; Windus G
    Unfallchirurg; 1987 Aug; 90(8):367-72. PubMed ID: 3659935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.